Company / Book Value per Share
NovaBay Pharmaceuticals, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.026
FY2024
5-year range
-$0.026 / $5.186
FY2020-FY2024
Trend
-108.9%
vs FY2023
Sector context
#192 of 211
Health Care
What the data says
Among 211 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 9% for book value per share. Book Value per Share has fluctuated over the past 10 years, ranging from -$2.468 in FY2015 to $5.186 in FY2022.
Based on SEC 10-K filings.
-$0.026 in FY2024.
Declined from $5.186 to -$0.026 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 211This company -$0.026 Sector average $213.854
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, book value per share decreased 108.9% year-over-year.
- Ranks #192 out of 211 companies in the Health Care sector.
- Peak book value per share was recorded in FY2022.
- Lowest book value per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.026 | -108.9% |
| FY2023 | $0.295 | -94.3% |
| FY2022 | $5.186 | +2126.1% |
| FY2021 | $0.233 | -33.7% |
| FY2020 | $0.351 | +681.1% |
| FY2019 | $0.045 | -84.5% |
| FY2018 | $0.29 | +70.9% |
| FY2017 | $0.17 | -91.7% |
| FY2016 | $2.037 | +182.6% |
| FY2015 | -$2.468 | -6058.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026